Laropharm S.R.L. Sustainability Profile
Laropharm S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across Eastern Europe. Founded in 1998, the company has established itself as a leader in the development and distribution of high-quality pharmaceutical products, particularly in the fields of oncology, cardiology, and neurology. With a commitment to innovation, Laropharm S.R.L. offers a diverse portfolio of prescription medications and over-the-counter solutions that stand out for their efficacy and safety. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, Laropharm S.R.L. continues to contribute to the advancement of healthcare, making a meaningful impact on patients' lives across the region.
DitchCarbon Score
How does Laropharm S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laropharm S.R.L.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laropharm S.R.L.'s reported carbon emissions
In 2022, Laropharm S.R.L. reported total carbon emissions of approximately 9,937,240 kg CO2e from Scope 1 sources and about 5,259,210 kg CO2e from Scope 2 (location-based). This brings their combined Scope 1 and 2 emissions to around 15,196,500 kg CO2e. Compared to 2021, where emissions were approximately 11,391,000 kg CO2e for Scope 1 and about 4,339,510 kg CO2e for Scope 2, there has been a notable reduction in emissions, particularly in Scope 1. The company has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi). Additionally, there are no documented climate pledges or reduction initiatives currently in place. Overall, Laropharm S.R.L. is actively monitoring its carbon footprint, with a focus on reducing its Scope 1 and 2 emissions, but further commitments and targets would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 10,920,800 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 3,604,070 | 0,000,000 | 0,000,000 | - |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Laropharm S.R.L.'s Industry?
How Carbon Intensive is Laropharm S.R.L.'s Location?
Laropharm S.R.L.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Laropharm S.R.L. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
